Direktorat Registrasi ObatValid

METRONIDAZOLE

BPOM Number: GKL0934008410B1
Approved: 22 July 2025
Expiry: 25 April 2030
Form: Tablet

About This Registration

METRONIDAZOLE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL0934008410B1. Its current registration status is Valid, with the licence valid until 25 April 2030. The product is registered to NOVAPHARIN - INDONESIA. BPOM first approved this registration in July 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: newaero
Packaging: DUS, 10 STRIP @ 10 TABLET
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

NOVAPHARIN - INDONESIA
KAB. GRESIK
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

NOVAPHARIN - INDONESIA
KAB. GRESIK
primary
View profile →

Ingredients (1)

METRONIDAZOLE

Market Intelligence

Owner Portfolio: NOVAPHARIN - INDONESIA holds 165 BPOM registrations
Manufacturer Scale: NOVAPHARIN - INDONESIA produces 165 registered products
Registration Age: Registered for 11 months

FDA Cross-Reference

via openFDA

Generic Name: METRONIDAZOLE
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?